Zhien Zhou

679 total citations
30 papers, 376 citations indexed

About

Zhien Zhou is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Molecular Biology. According to data from OpenAlex, Zhien Zhou has authored 30 papers receiving a total of 376 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 10 papers in Rheumatology and 8 papers in Molecular Biology. Recurrent topics in Zhien Zhou's work include Prostate Cancer Diagnosis and Treatment (18 papers), Prostate Cancer Treatment and Research (16 papers) and Urologic and reproductive health conditions (10 papers). Zhien Zhou is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (18 papers), Prostate Cancer Treatment and Research (16 papers) and Urologic and reproductive health conditions (10 papers). Zhien Zhou collaborates with scholars based in China. Zhien Zhou's co-authors include Weigang Yan, Yi Zhou, Yu Xiao, Xingcheng Wu, Hanzhong Li, Zhiyong Liang, Zhigang Ji, Shancheng Ren, Jian Chen and Yanqing Wang and has published in prestigious journals such as Medicine, Cell Death and Disease and Urology.

In The Last Decade

Zhien Zhou

30 papers receiving 375 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhien Zhou China 12 168 163 158 47 45 30 376
Clemens Thoma United States 8 170 1.0× 52 0.3× 94 0.6× 18 0.4× 11 0.2× 106 361
Mihyang Ha South Korea 10 177 1.1× 79 0.5× 77 0.5× 16 0.3× 6 0.1× 30 302
Eisuke Tomiyama Japan 13 248 1.5× 135 0.8× 151 1.0× 18 0.4× 13 0.3× 33 502
He Du China 9 186 1.1× 107 0.7× 79 0.5× 17 0.4× 7 0.2× 26 323
Lijuan Bian China 11 157 0.9× 130 0.8× 40 0.3× 17 0.4× 10 0.2× 19 311
Xiushan Zheng China 11 266 1.6× 222 1.4× 94 0.6× 58 1.2× 4 0.1× 18 445
Fangdie Ye China 13 223 1.3× 154 0.9× 151 1.0× 35 0.7× 4 0.1× 34 395
Masataka Shimonosono Japan 10 124 0.7× 104 0.6× 77 0.5× 12 0.3× 8 0.2× 29 286
Chien‐An Liu Taiwan 12 66 0.4× 78 0.5× 172 1.1× 62 1.3× 8 0.2× 34 481
Ankui Yang China 15 253 1.5× 167 1.0× 72 0.5× 12 0.3× 9 0.2× 25 442

Countries citing papers authored by Zhien Zhou

Since Specialization
Citations

This map shows the geographic impact of Zhien Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhien Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhien Zhou more than expected).

Fields of papers citing papers by Zhien Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhien Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhien Zhou. The network helps show where Zhien Zhou may publish in the future.

Co-authorship network of co-authors of Zhien Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Zhien Zhou. A scholar is included among the top collaborators of Zhien Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhien Zhou. Zhien Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liang, Zhen, Yu Xiao, Boju Pan, et al.. (2024). Can a nomogram predict apical prostate cancer pathology upgrade from fusion biopsy to final pathology? A multicenter study. Cancer Medicine. 13(11). e7341–e7341. 1 indexed citations
2.
Chen, Yuliang, Zhien Zhou, Yi Zhou, et al.. (2024). Updated prevalence of latent prostate cancer in Chinese population and comparison of biopsy results: An autopsy-based study. The Innovation. 5(1). 100558–100558. 5 indexed citations
3.
Zuo, Yuzhi, Zhen Liang, Boju Pan, et al.. (2024). Clinical Characteristics of Adrenal Hemangioma. Journal of the Endocrine Society. 8(5). bvae041–bvae041. 2 indexed citations
4.
5.
Wu, Xingcheng, Yu‐Zhong Yu, Yuzhi Zuo, et al.. (2022). Identification of UAP1L1 as a critical factor for prostate cancer and underlying molecular mechanism in tumorigenicity. Journal of Translational Medicine. 20(1). 91–91. 7 indexed citations
6.
Zhou, Zhien, et al.. (2021). Unilateral lesion detected on preoperative multiparametric magnetic resonance imaging and MRI/US fusion-guided prostate biopsy is not an appropriate indication for focal therapy in prostate cancer. Urologic Oncology Seminars and Original Investigations. 39(10). 730.e17–730.e22. 6 indexed citations
7.
Chen, Yuliang, Zhien Zhou, Yi Zhou, et al.. (2021). Development and internal validation of a prediction model of prostate cancer on initial transperineal template-guided prostate biopsy. BMC Urology. 21(1). 68–68. 3 indexed citations
8.
Zhou, Zhien, et al.. (2021). Long non‐coding RNA ADAMTS9‐AS1 inhibits the progression of prostate cancer by modulating the miR‐142‐5p/CCND1 axis. The Journal of Gene Medicine. 23(5). e3331–e3331. 18 indexed citations
9.
10.
11.
Zhou, Zhien, et al.. (2021). [Effect of self-made Qingyuan Shenghua decoction on coagulation dysfunction in patients with sepsis].. PubMed. 33(8). 944–948. 1 indexed citations
12.
Zheng, Zhibo, Zhien Zhou, Weigang Yan, et al.. (2020). Tumor characteristics, treatments, and survival outcomes in prostate cancer patients with a PSA level < 4 ng/ml: a population-based study. BMC Cancer. 20(1). 340–340. 12 indexed citations
13.
Xu, Lili, Gumuyang Zhang, Daming Zhang, et al.. (2020). Comparison of PI-RADS version 2.1 and PI-RADS version 2 regarding interreader variability and diagnostic accuracy for transition zone prostate cancer. Abdominal Radiology. 45(12). 4133–4141. 17 indexed citations
14.
Zhou, Yi, Zhien Zhou, Zhigang Ji, et al.. (2020). Tetramethylpyrazine reduces prostate cancer malignancy through inactivation of the DPP10‑AS1/CBP/FOXM1 signaling pathway. International Journal of Oncology. 57(1). 314–324. 14 indexed citations
15.
Zhou, Zhien, Yinyan Xu, Weigang Yan, et al.. (2019). <p>Prognostic significance of a novel indicator (PSA<sub>postd3</sub>/PSA<sub>pre</sub>) for PSA recurrence in patients after radical prostatectomy</p>. Cancer Management and Research. Volume 11. 5777–5783. 1 indexed citations
16.
Wu, Xingcheng, Yu Xiao, Yi Zhou, Zhien Zhou, & Weigang Yan. (2019). LncRNA FOXP4-AS1 is activated by PAX5 and promotes the growth of prostate cancer by sequestering miR-3184-5p to upregulate FOXP4. Cell Death and Disease. 10(7). 472–472. 97 indexed citations
17.
Zhou, Yi, Zhien Zhou, Yinyan Xu, et al.. (2018). Diagnostic accuracy of magnetic resonance-guided prostate biopsy and template-guided transperineal saturation biopsy. Medicine. 97(38). e12495–e12495. 6 indexed citations
18.
Zhou, Yi, Zhigang Ji, Weigang Yan, Zhien Zhou, & Hanzhong Li. (2017). The biological functions and mechanism of miR-212 in prostate cancer proliferation, migration and invasion via targeting Engrailed-2. Oncology Reports. 38(3). 1411–1419. 16 indexed citations
19.
Xia, Zenan, et al.. (2017). An Unusual Right-sided Suprarenal Accessory Spleen Misdiagnosed as an Atypical Pheochromocytoma. Urology. 110. e1–e2. 4 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Clemens Thoma Breakdown of academic impact, for papers by Mihyang Ha Breakdown of academic impact, for papers by Eisuke Tomiyama Breakdown of academic impact, for papers by He Du Breakdown of academic impact, for papers by Lijuan Bian Breakdown of academic impact, for papers by Xiushan Zheng Breakdown of academic impact, for papers by Fangdie Ye Breakdown of academic impact, for papers by Masataka Shimonosono Breakdown of academic impact, for papers by Chien‐An Liu Breakdown of academic impact, for papers by Ankui Yang
Rankless by CCL
2026